Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medilife Health Sciences is an Indian pharmaceutical company focused on the manufacturing, marketing, and distribution of hospital-focused products, particularly injectable life-saving medicines, large volume parenterals, and critical care products. The company presents itself as a WHO-GMP and ISO-certified manufacturer with QA/QC-supported production, central warehousing, and distribution capabilities across multiple Indian states. Its commercial portfolio includes tertiary care anti-infectives, ICU and hospital injectables, parenteral nutrition-related offerings, and healthcare products sold under divisions such as Criticare, Hospicare, and Oncocare. Available public information suggests that Medilife is a commercial-stage specialty pharma business rather than a drug discovery biotech. The company appears primarily focused on affordable formulations and branded generics for the Indian hospital market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medilife.